ClassID:

92685

C07C229/26 - CPC Classification

Classification description:

Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Recent Application in this class:
#1
20260085030
2026-03-26

ARTEMISINIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#2
20260055055
2026-02-26

PROCESS FOR MAKING SELADELPAR

#3
20260001834
2026-01-01

COMPOUND OR SALT THEREOF, LIPID COMPOSITION, PHARMACEUTICAL COMPOSITION, AND DELIVERY CARRIER

#4
20250296915
2025-09-25

NOVEL AMINO ACID DERIVATIVES

#5
20250270167
2025-08-28

UNNATURAL AMINO ACID AND USE THEREOF, RECOMBINANT PROTEIN CONTAINING SAME AND RECOMBINANT PROTEIN CONJUGATE

#6
20250171406
2025-05-29

AMINO ACID COMPOSITIONS

#7
20250163001
2025-05-22

AMINO ACID COMPOSITIONS

#8
20250163000
2025-05-22

AMINO ACID COMPOSITIONS

#9
20250162999
2025-05-22

AMINO ACID COMPOSITIONS

#10
20250162998
2025-05-22

AMINO ACID COMPOSITIONS

#11
20250162997
2025-05-22

AMINO ACID COMPOSITIONS

#12
20250162996
2025-05-22

AMINO ACID COMPOSITIONS

#13
20250145560
2025-05-08

COMPOUND AS MANUFACTURING INTERMEDIATE OF AMINOLIPID OR SALT THEREOF AND METHOD FOR MANUFACTURING AMINOLIPID COMPOUND USING THE COMPOUND

#14
20250074874
2025-03-06

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

#15
20250073250
2025-03-06

Improved synthesis of lysine acetylsalicylate - Glycine particles

#16
20250051264
2025-02-13

CANNABIDIOL DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#17
20250051263
2025-02-13

NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME

#18
20250019370
2025-01-16

L-LYSINE SALT OF 4-CHLORO-5-[4-(2,6-DICHLOROPHENYL)SULFONYLPIPERAZIN-1-YL]-1-BENZOFURAN-2-CARBOXYLIC ACID AND VARIOUS FORMS THEREOF

#19
20250002530
2025-01-02

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#20
20240368088
2024-11-07

EP4 ANTAGONIST COMPOUND AS WELL AS SALT, POLYMORPH AND USE THEREOF

#21
20240342088
2024-10-17

CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND FORMULATION AND APPLICATION THEREOF

#22
20240335384
2024-10-10

NITROGEN-CONTAINING CATIONIC LIPID AND APPLICATION THEREOF

#23
20240308953
2024-09-19

SOLUBLE CHELATOR FOR TARGETING RECOMBINANT PROTEINS

#24
20240174598
2024-05-30

COMPOUNDS FOR THE TREATMENT OF DISORDERS AND SALTS AND POLYMORPHS THEREOF

#25
20240124389
2024-04-18

COMPOUND OR SALT THEREOF, LIPID PARTICLES, AND PHARMACEUTICAL COMPOSITION

#26
20230357121
2023-11-09

CO-CRYSTAL OF KETOPROFEN, LYSINE AND GABAPENTIN, PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE

#27
20230303930
2023-09-28

Quaternary ammonium salt for use as a cationic surfactant

#28
20230257349
2023-08-17

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

#29
20230234912
2023-07-27

NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS

#30
20230203079
2023-06-29

Amino Acid Composition and Method for Catalytic Synthesis of Amino Acid by Means of Energy Radiation

#31
20230124955
2023-04-20

AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF

#32
20230100940
2023-03-30

DNP and DNP Prodrug Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss and/or Metabolic Diseases

#33
20220315529
2022-10-06

NITRILOTRIACETIC ACID-CONTAINING LIPIDOID NANOPARTICLES

#34
20220298125
2022-09-22

3-(5-CHLORO-2-OXOBENZO[D]OXAZOL-3(2H)-YL) PROPANOIC ACID DERIVATIVES AS KMO INHIBITORS

#35
20220265590
2022-08-25

DIBENZYLAMINES AS AMINO ACID TRANSPORT INHIBITORS

#36
20220177412
2022-06-09

CARBON QUANTUM DOT, A COMPOSITION THEREOF AND A METHOD FOR TREATING INFECTION BY USING SAME

#37
20220162155
2022-05-26

L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF

#38
20220041553
2022-02-10

APOE4-TARGETED THERAPUTICS THAT INCREASE SIRT1

#39
20220031851
2022-02-03

Compositions and methods relating to salts of specialized pro-resolving mediators

#40
20220009878
2022-01-13

IONIZABLE AMINE LIPIDS

#41
20210269412
2021-09-02

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES AND CANCER

#42
20210261493
2021-08-26

CRYSTAL OF AMINO ACID SALT OF 3-HYDROXYISOVALERIC ACID AND PRODUCTION METHOD THEREOF

#43
20210253517
2021-08-19

Method for producing amino acid aminoalkyl ester or inorganic acid salt thereof

#44
20210206713
2021-07-08

Compounds and methods for the treatment of neurodegenerative diseases

#45
20210171437
2021-06-10

PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY AND NOVEL INTERMEDIATES AND METHODS RELATED THERETO

#46
20210138072
2021-05-13

Compositions and methods relating to salts of specialized pro-resolving mediators

#47
20210040149
2021-02-11

Aromatic-cationic peptides and uses of same

#48
20200407316
2020-12-31

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

#49
20200330501
2020-10-22

Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof

#50
20200317991
2020-10-08

Branched geminal zwitterionic liquids, method for obtaining same and use thereof as wettability modifiers having viscosity reducing properties

#51
20200297678
2020-09-24

Amino acid compositions

#52
20200239406
2020-07-30

L-ornithine phenyl acetate and methods of making thereof

#53
20200216383
2020-07-09

Polyaspartic acid ester compositions which contain polyaspartic acid esters with primary amino groups and small amounts of fumaric acid dialkyl esters

#54
20200199157
2020-06-25

Methods for synthesizing zinc-lysine-chloride complex

#55
20200199156
2020-06-25

Methods for synthesizing zinc-lysine-chloride complex

#56
20200181064
2020-06-11

PHARMACEUTICALLY ACCEPTABLE SALTS OF FATTY ACIDS

#57
20200179521
2020-06-11

Compositions and methods relating to salts of specialized pro-resolving mediators

#58
20200157033
2020-05-21

Processes of making L-ornithine phenylacetate

#59
20200148661
2020-05-14

Alpha-tea salt forms: compositions and uses for treating disease

#60
20200095190
2020-03-26

Glutamine transport inhibitors and methods for treating cancer

#61
20200093831
2020-03-26

DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases

#62
20190345117
2019-11-14

3-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitors

#63
20190270698
2019-09-05

COMPOUNDS AND METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

#64
20190263825
2019-08-29

WATER SOLUBLE SALTS OF ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF DIABETIC COMPLICATIONS

#65
20190223814
2019-07-25

18F labeled amino acids, derivatives thereof and method of making same

#66
20190210958
2019-07-11

Crystal of amino acid salt of 3-hydroxyisovaleric acid and production method thereof

#67
20190161515
2019-05-30

Materials and methods for detection and quantification of β-N-methylamino-L-alanine

#68
20190135752
2019-05-09

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

#69
20190076462
2019-03-14

Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof

#70
20190055190
2019-02-21

PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY AND NOVEL INTERMEDIATES AND METHODS RELATED THERETO

#71
20190040479
2019-02-07

Ionic liquid and method for dissolving cellulose using the same

#72
20180362579
2018-12-20

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#73
20180319736
2018-11-08

L-ornithine phenyl acetate and methods of making thereof

#74
20180305311
2018-10-25

Synergistic compositions

#75
20180305297
2018-10-25

DTPA PRODRUGS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME

#76
20180303145
2018-10-25

Isotopically modified compounds and their use as food supplements

#77
20180282310
2018-10-04

FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON'S TYROSINE KINASE

#78
20180215942
2018-08-02

Ionic liquid composition and method for dissolving cellulose using the same

#79
20180193476
2018-07-12

Enzymatic conjugation of antibodies

#80
20180162894
2018-06-14

Processes for the preparation of GalNAc acid derivatives

#81
20180148390
2018-05-31

METHOD AND COMPOSITION FOR RETAINING NUTRIENTS IN SOIL AT PLANTING SITES

#82
20180118661
2018-05-03

Compounds and methods for the treatment of neurodegenerative diseases

#83
20180118655
2018-05-03

Pharmaceutically acceptable salts of fatty acids

#84
20180110751
2018-04-26

Compositions and methods relating to salts of specialized pro-resolving mediators

#85
20180105890
2018-04-19

Ionic liquid and method for dissolving cellulose using the same

#86
20180100173
2018-04-12

Gluconate repressor variant, microorganism containing the same producing L-lysine, and method for producing L-lysine

#87
20180099991
2018-04-12

SALTS OF OBETICHOLIC ACID

#88
20180071402
2018-03-15

ENZYMATIC CONJUGATION OF POLYPEPTIDES

#89
20180044281
2018-02-15

L-ornithine phenyl acetate and methods of making thereof

#90
20180021285
2018-01-25

METHOD FOR VISUALIZATION OF CALCIUM CONTAINING COMPONENTS IN BIOLOGICAL SYSTEMS

#91
20170362237
2017-12-21

WATER SOLUBLE SALTS OF ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF DIABETIC COMPLICATIONS

#92
20170335171
2017-11-23

Branched geminal zwitterionic liquids, method for obtaining same and use thereof as wettability modifiers having viscosity reducing properties

#93
20170325457
2017-11-16

FORMULATIONS FOR THE DELIVERY OF ACTIVE AGENTS TO INSECTS, PLANTS, AND PLANT PATHOGENS

#94
20170320823
2017-11-09

Synergistic compositions

#95
20170226139
2017-08-10

CRYSTALLINE SALTS OF (Z)-O-OCTADEC-9-EN-1-YL O,O-DIHYDROGEN PHOSPHOROTHIOATE

#96
20170226059
2017-08-10

APOE4-TARGETED THERAPUTICS THAT INCREASE SIRT1

#97
20170190663
2017-07-06

Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-hepatonic acid

#98
20170172195
2017-06-22

Isotopically modified compounds and their use as food supplements

#99
20170137460
2017-05-18

Short chain PEGylation of amino acid monomers glutamine, lysine and peptides formed thereby

#100
20170088506
2017-03-30

DTPA prodrugs, compositions thereof, and methods of using the same

#101
20170044087
2017-02-16

Anaerobic curable compositions containing blocked (meth)acrylate acid compounds

#102
20170022227
2017-01-26

Crystallization method and bioavailability

#103
20160340374
2016-11-24

Borate-based base generator, and base-reactive composition comprising such base generator

#104
20160332950
2016-11-17

Compositions and methods for the treatment of urea cycle disorders and gout

#105
20160318884
2016-11-03

3-(5-CHLORO-2-OXOBENZO[D]OXAZOL-3(2H)-YL) PROPANOIC ACID DERIVATIVES AS KMO INHIBITORS

#106
20160311762
2016-10-27

HYDRAZINYL LIPIDOIDS AND USES THEREOF

#107
20160304663
2016-10-20

Polyester polyquaternary ammonium compound collectors for reverse froth flotation of silicates from nonsulfidic ores

#108
20160304553
2016-10-20

ARAMCHOL SALTS

#109
20160289220
2016-10-06

Salts

#110
20160264530
2016-09-15

N, N, N-trialkyl histidine derivatives useful for the preparation of ergothioneine compounds

#111
20160214954
2016-07-28

Alpha-TEA salt forms: compositions and uses for treating disease

#112
20160185720
2016-06-30

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic-acid

#113
20160068484
2016-03-10

Synergistic compositions

#114
20160016982
2016-01-21

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

#115
20160016890
2016-01-21

Lysine isotopologues, compositions comprising the same and methods of synthesis

#116
20150335618
2015-11-26

Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders

#117
20150284325
2015-10-08

Crystalline phase of (3S.3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine

#118
20150251999
2015-09-10

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-hepatanoic acid

#119
20150251990
2015-09-10

L-ornithine phenyl acetate and methods of making thereof

#120
20150212020
2015-07-30

Stable isotope-labeled aliphatic amino acid and NMR structural analysis of protein using same

#121
20150197483
2015-07-16

METHODS AND COMPOSITIONS FOR MAKING AN AMINO ACID TRIHYDROCHLORIDE

#122
20150190522
2015-07-09

Transfection reagents

#123
20150183726
2015-07-02

Crystalline salts of (Z)-O-octadec-9-en-1-yl O,O-dihydrogen phosphorothioate

#124
20150152125
2015-06-04

Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

#125
20150152034
2015-06-04

Pharmaceutically acceptable salts of fatty acids

#126
20150023900
2015-01-22

Amino acid-modified siloxanes, process for preparing them and application

#127
20140356385
2014-12-04

Enzymatic conjugation of antibodies

#128
20140336395
2014-11-13

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid

#129
20140323719
2014-10-30

Process for the purification of polyaminocarboxylates

#130
20140312218
2014-10-23

Covalently functionalized nanodiamond-based MALDI matrices and methods of use thereof

#131
20140308304
2014-10-16

LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

#132
20140294796
2014-10-02

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#133
20140288327
2014-09-25

L-ornithine phenyl acetate and methods of making thereof

#134
20140288142
2014-09-25

Nitric oxide donor compounds

#135
20140275407
2014-09-18

Aspartic resins

#136
20140243251
2014-08-28

Process for producing granules comprising one or more complexing agent salts

#137
20140228435
2014-08-14

COMPOSITION AND METHOD OF SYNTHESIZING A BIOMOLECULE AND ITS THERAPEUTICS APPLICATIONS

#138
20140187630
2014-07-03

NOVEL COMPOUND AND MEDICAL USE THEREOF

#139
20140161830
2014-06-12

Amine-containing lipidoids and uses thereof

#140
20140135399
2014-05-15

NOVEL POLYMORPHS AND SALTS

#141
20140128430
2014-05-08

Amine salts of laquinimod

#142
20140094393
2014-04-03

Composition and method for reducing hydrate agglomeration

#143
20140038987
2014-02-06

Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders

#144
20140031403
2014-01-30

Solid forms of curcumin

#145
20130259897
2013-10-03

Crystalline forms of (R)-3-[N-(3'-chlorobiphenyl-4-ylmethyl)-N'-(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxyproprionic acid isopropyl ester

#146
20130210848
2013-08-15

Salt of a pyrimidin derivative

#147
20130189287
2013-07-25

Enzymatic conjugation of polypeptides

#148
20130158241
2013-06-20

Process for Preparing Crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic Acid and Use for Production of Primovist®

#149
20130158021
2013-06-20

Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof

#150
20130096340
2013-04-18

AMINO ACID GROUP-MODIFIED ORGANOPOLYSILOXANE AND SILANE, AMINO ACID GROUP-CONTAINING COMPOUND, AND PRODUCTION METHOD THEREOF

#151
20120309983
2012-12-06

Amino acid group-modified organopolysiloxane and silane, amino acid group-containing compound, and production method thereof

#152
20120289471
2012-11-15

NOVEL COMPOUNDS WITH HIGH THERAPEUTIC INDEX

#153
20120264934
2012-10-18

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid

#154
20120238747
2012-09-20

Transfection reagents

#155
20120226048
2012-09-06

Paramagnetic polynuclear metal complex having high self-relaxation rate, preparation method thereof, and contrast medium containing same

#156
20120208885
2012-08-16

L-ornithine phenyl acetate and methods of making thereof

#157
20120157351
2012-06-21

Composition and method for reducing hydrate agglomeration

#158
20120136073
2012-05-31

Amine-Containing Transfection Reagents and methods for making and using same

#159
20120116106
2012-05-10

Co-precipitated salts of fatty acids

#160
20120095262
2012-04-19

Nicotianamine-derived metallophore and processes for producing same

#161
20120077727
2012-03-29

Process for producing granules comprising one or more complexing agent salts

#162
20110319365
2011-12-29

Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents

#163
20110313043
2011-12-22

Amino acid compositions

#164
20110263539
2011-10-27

SHIP 1 MODULATOR COMPOUNDS

#165
20110245346
2011-10-06

Polymorphs and salts

#166
20110237813
2011-09-29

Co-precipitated salts of fatty acids

#167
20110195935
2011-08-11

NITRIC OXIDE RELEASING AMINO ACID ESTER COMPOUND, COMPOSITION AND METHOD OF USE

#168
20110172443
2011-07-14

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, alpha-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid

#169
20110166380
2011-07-07

Derivative compounds of N-6-Trimethy-L-Lysine for therapeutic use

#170
20110166379
2011-07-07

Method of synthesis and purification of N-6-trimethyl-L-lysine and derivative compounds

#171
20110166231
2011-07-07

Method of treating a human being for a class of metabolic defects and energy production disorders

#172
20110166230
2011-07-07

Method of treating a human being for a class of neurological defects and seizure disorders

#173
20110144369
2011-06-16

Amino acid group-modified organopolysiloxane and silane, amino acid group-containing compound, and production method thereof

#174
20110130409
2011-06-02

Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders

#175
20110082208
2011-04-07

Therapies for cancer using isotopically substituted lysine

#176
20100323990
2010-12-23

SHIP 1 MODULATOR PRODRUGS

#177
20100280120
2010-11-04

COMPOUND INDUCING ANGIOGENESIS RESPONSE IN ISCHAEMIC TISSUES

#178
20100280119
2010-11-04

L-ornithine phenyl acetate and methods of making thereof

#179
20100202998
2010-08-12

USE OF AT LEAST ONE LYSINE-DERIVED COMPOUND FOR THE CONDITIONING OF KERATINOUS FIBERS, COSMETIC COMPOSITION COMPRISING IT AND METHOD FOR CONDITIONING THE FIBERS

#180
20100160248
2010-06-24

Isotopically modified compounds and their use as food supplements

#181
20100159593
2010-06-24

Transfection reagents

#182
20100130432
2010-05-27

Non-Natural Amino Acids and Neurotensin Analogues Thereof

#183
20100120727
2010-05-13

Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof

#184
20100105775
2010-04-29

Amino acid salts of prostaglandins

#185
20100105771
2010-04-29

Amino acid salts of prostaglandins

#186
20100099729
2010-04-22

NITRIC OXIDE DONOR COMPOUNDS

#187
20100080856
2010-04-01

Method and composition for postoperative wound healing

#188
20100069489
2010-03-18

L-THREONINE DERIVATIVES OF HIGH THERAPEUTIC INDEX

#189
20100069446
2010-03-18

L-threonine derivatives of high therapeutic index

#190
20100056628
2010-03-04

Preservative compositions

#191
20100004481
2010-01-07

L-Threonine derivatives of high therapeutic index

#192
20090281347
2009-11-12

Method for producing amino acid phosphates

#193
20090264620
2009-10-22

N-Methylation of amino acids

#194
20090226524
2009-09-10

Stable active compound complex of salts of o-acetylsalicylic acid with basic amino acids and glycine

#195
20090203781
2009-08-13

N-N-Acyloxypropyl Lysine Methyl Ester-and N,N-Bis(N-Acyloxypropyl) Lysine Methyl Ester-Type Compounds and Use Thereof as Surface-Active Agents with an Antimicrobial Activity

#196
20090149673
2009-06-11

SYNTHETIC NON-FOULING AMINO ACIDS

#197
20090149415
2009-06-11

Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex

#198
20090143583
2009-06-04

Transfection reagents

#199
20090136417
2009-05-28

GLYCEROL ESTER DERIVATIVE HAVING METAL CHELATE STRUCTURE

#200
20090082594
2009-03-26

Crystals of L-ornithine and process for producing the same

#201
20090075388
2009-03-19

Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins

#202
20090075348
2009-03-19

Method for recovering a basic amino acid from a fermentation liquor

#203
20090054685
2009-02-26

Methods for purifying amino acids

#204
20090048453
2009-02-19

Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid

#205
20090041681
2009-02-12

Anti-inflammatory inhalation pharmaceutical composition

#206
20080281113
2008-11-13

Preparation of amino acid-fatty acid anhydrides

#207
20080267945
2008-10-30

Salts of isophosphoramide mustard and analogs thereof as anti-tumor Agents

#208
20080255385
2008-10-16

METHOD FOR PRODUCING OPTICALLY ACTIVE (4E)-5-CHLORO-2-ISOPROPYL-4-PENTENOIC ACID OR BASIC AMINO ACID SALT THEREOF

#209
20080227847
2008-09-18

Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use

#210
20080221377
2008-09-11

Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediates

#211
20080213206
2008-09-04

Cosmetic Composition Comprising at Least One Fatty-Chain Polylysine, Which is Intended to Improve the Surface State of Keratin Fibers

#212
20080200725
2008-08-21

Preparation of amino acid-fatty acid anhydrides

#213
20080200443
2008-08-21

Zinc complexes of natural amino acids for treating elevated copper caused toxicities

#214
20080193985
2008-08-14

Method For Recovering a Basic Amino Acid Form a Fermentation Liquor ll

#215
20080188652
2008-08-07

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid

#216
20080177035
2008-07-24

Methods for making intermediates and oxytocin analogues

#217
20080171872
2008-07-17

Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)Carbonyl]-1H-pyrrole-1-heptanoic acid

#218
20080107746
2008-05-08

Anti-inflamatory inhalation pharmaceutical composition

#219
20080015386
2008-01-17

Crystal of L-Ornithine-Citric Acid Salt

#220
20070202600
2007-08-30

Transfection reagents

#221
20070202598
2007-08-30

Transfection reagents

#222
20070167424
2007-07-19

Aztreonam L-lysine and methods for the preparation and analysis thereof

#223
20060287244
2006-12-21

L-Threonine derivatives of high therapeutic index

#224
20060281945
2006-12-14

Method of making a diL-lysine monosulfate trihydrate crystal

#225
20060264406
2006-11-23

Mono-lysine salts of azole compounds

#226
20060247274
2006-11-02

Substituted amino acids as erythropoietin mimetics

#227
20060247157
2006-11-02

Methods for making intermediates and oxytocin analogues

#228
20060241017
2006-10-26

Compounds with high therapeutic index

#229
20060089333
2006-04-27

Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

#230
20060035972
2006-02-16

Therapeutic compositions and uses

#231
20060004103
2006-01-05

Method for producing lysine derivative

#232
20050260597
2005-11-24

Transfection reagents

#233
20050171070
2005-08-04

Stable salts of o-acetylsalicylic acid containing basic amino acids II

#234
20050164972
2005-07-28

Transfection reagents

#235
20050164971
2005-07-28

New transfection reagents

#236
20050164391
2005-07-28

Transfection reagents

#237
20050143586
2005-06-30

Process for producing optically active amino acid derivatives

#238
20050132947
2005-06-23

DiL-lysine monosulfate trihydrate crystal and method of making

#239
20050124069
2005-06-09

Transfection reagents

#240
20050084452
2005-04-21

Stable isotope-labeled amino acid and method for incorporating same into target protein

#241
20050032775
2005-02-10

Aztreonam L-lysine and methods for the preparation thereof

#242
20050009791
2005-01-13

Stable salts of O-acetylsalicylic acid with basic amino acids

#243
18745858
2025-10-21

Amino acid compositions

#244
17522680
2025-02-18

Amino acid compositions

#245
17522668
2025-03-04

Amino acid compositions

#246
14065372
2019-11-12

Amino acid supplement formulations

#247
14065371
2019-10-08

Amino acid compositions